Royce & Associates LP raised its stake in inTEST Co. (NYSE:INTT – Free Report) by 9.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,219,157 shares of the company’s stock after buying an additional 110,078 shares during the period. Royce & Associates LP owned 0.10% of inTEST worth $8,900,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Pacific Ridge Capital Partners LLC increased its holdings in shares of inTEST by 23.1% in the second quarter. Pacific Ridge Capital Partners LLC now owns 460,914 shares of the company’s stock valued at $4,554,000 after purchasing an additional 86,632 shares during the last quarter. CM Management LLC increased its holdings in shares of inTEST by 37.3% in the second quarter. CM Management LLC now owns 309,000 shares of the company’s stock valued at $3,053,000 after purchasing an additional 84,000 shares during the last quarter. American Century Companies Inc. acquired a new position in shares of inTEST in the second quarter valued at $145,000. Allspring Global Investments Holdings LLC increased its holdings in shares of inTEST by 21.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 14,153 shares of the company’s stock valued at $188,000 after purchasing an additional 2,476 shares during the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in shares of inTEST in the second quarter valued at $1,218,000. 63.18% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of brokerages have recently issued reports on INTT. Northland Securities boosted their target price on shares of inTEST from $10.00 to $13.00 and gave the company a “market perform” rating in a research report on Monday, November 4th. Northland Capmk cut shares of inTEST from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 5th.
inTEST Trading Up 0.3 %
Shares of inTEST stock opened at $7.43 on Monday. The firm has a 50-day moving average of $7.17 and a 200-day moving average of $8.58. The stock has a market cap of $91.98 million, a PE ratio of 32.31 and a beta of 1.92. inTEST Co. has a 52-week low of $6.28 and a 52-week high of $14.35. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26.
inTEST (NYSE:INTT – Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.03. inTEST had a net margin of 2.33% and a return on equity of 5.31%. The business had revenue of $30.27 million during the quarter, compared to analysts’ expectations of $32.97 million. As a group, sell-side analysts forecast that inTEST Co. will post 0.41 EPS for the current year.
Insider Buying and Selling
In related news, CEO Richard N. Jr. Grant sold 6,788 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $6.97, for a total transaction of $47,312.36. Following the completion of the sale, the chief executive officer now owns 164,929 shares of the company’s stock, valued at $1,149,555.13. This represents a 3.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 5.50% of the stock is currently owned by company insiders.
About inTEST
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Read More
- Five stocks we like better than inTEST
- The 3 Best Fintech Stocks to Buy Now
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- About the Markup Calculator
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding INTT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for inTEST Co. (NYSE:INTT – Free Report).
Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.